Ex Vivo Models for Studying Thrombosis: Special Emphasis on Shear Rate Dependent Blood-Collagen Interactions

  • Kjell S. Sakariassen
  • Helge E. Roald
  • José Aznar Salatti
Part of the NATO ASI Series book series (NSSA, volume 235)

Abstract

Perfusion models that allow exposure of artery subendothelium, collagen and other surfaces to non-anticoagulated blood (ex vivo models) or to anticoagulated blood (in vitro models) under well controlled experimental conditions have given much useful information about thrombotic mechanisms(1–15) This includes a better understanding of molecular mechanisms of platelet-surface adhesion(3,6,13,16–19), platelet-platelet interactioe(3,13,16,20–23), and the interplay between coagulation and platelet function in thrombus formation(4,12–14,22–27) However, the blood flow, and in particular the shear rate, plays an unambiguous role in these events(1–3,13,14,16.17,19,21–25,28,29).

Keywords

Shear Rate Collagen Fibril Platelet Adhesion Blood Flow Rate Wall Shear Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baumgartner HR: The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi, Microvasc. Res., 5: 167, 1973.Google Scholar
  2. 2.
    Turitto VT, Baumgartner HR: Effect of physical factors on platelet adhesion to subendothelium, Thromb. Diath. Haemorrh. (Suppl), 60: 17, 1973.Google Scholar
  3. 3.
    Baumgartner HR, Muggli R: Adhesion and aggregation: morphological demonstration and quantitation in vivo and in vitro, In: Platelets in Biology and Pathology (Ed., Gordon JL ), Elsevier/North Holland Biomedical Press, Amsterdam, 1976.Google Scholar
  4. 4.
    Baumgartner HR: Effects of anticoagulation on the interaction of human platelets with subendothelium in flowing blood, Schweitz. Med. Wschr., 106: 1367, 1976.Google Scholar
  5. 5.
    Muggli R, Baumgartner HR, Tschopp TB, Keller H: Automated microdensitometry and protein assays as a measure for platelet adhesion and aggregation on collagen coated slides under controlled flow conditions, J. Lab. Clin. Med., 95: 195, 1979.Google Scholar
  6. 6.
    Sakariassen KS, Bolhuis PA, Sixma JJ: Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium, Nature, 279: 636, 1979.CrossRefPubMedGoogle Scholar
  7. 7.
    Sakariassen KS, Aarts PAMM, de Groot PhG, Houdijk WPM, Sixma JJ: A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components, J. Lab. Clin. Med., 102: 522, 1983.PubMedGoogle Scholar
  8. 8.
    Frangos JA, Eskin SG, McIntire LV: Flow effects on prostacyclin production by cultured human endothelial cells, Science, 227: 1477, 1985.CrossRefPubMedGoogle Scholar
  9. 9.
    Hanson SR, Kotze HF, Savage B, Harker LA: Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons, Arteriosclerosis, 5: 595, 1985.CrossRefPubMedGoogle Scholar
  10. 10.
    Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V: Influence of artrial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model, Arteriosclerosis, 6: 312, 1986.CrossRefPubMedGoogle Scholar
  11. 11.
    Badimon L, Turitto V, Rosemark JA, Badimon JJ, Fuster V: Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labelled platelets on collagen, subendothelium, and expanded polytetrafluorethylene, J. Lab. Clin. Med., 110: 706, 1987.PubMedGoogle Scholar
  12. 12.
    Cadroy Y, Horbett TA, Hanson SR: Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo, J. Lab. Clin. Med., 113: 436, 1989.PubMedGoogle Scholar
  13. 13.
    Sakariassen KS, Muggli R, Baumgartner HR: Measurements of platelet interaction with components of the vessel wall in flowing blood, In: Methods in Enzymology, Academic Press Inc., New York, Vol. 169, 33, 1989.Google Scholar
  14. 14.
    Sakariassen KS, Joss R, Muggli R, Kuhn H, Tschopp TB, Sage H, Baumgartner HR: Collagen type III induced ex vivo thrombogenesis in humans: role of platelets and leukocytes in deposition of fibrin, Arteriosclerosis, 19: 276, 1990.Google Scholar
  15. 15.
    Grabowski EF: Platelet aggregation in flowing blood at a site of injury to an endothelial cell monolayer: quantitation and real-time imaging with the TAB monoclonal antibody, Blood, 75: 390, 1990.PubMedGoogle Scholar
  16. 16.
    Baumgartner HR, Muggli R, Tschopp TB, Turitto VT: Platelet adhesion, release reaction and aggregation in flowing blood: effects of surface properties and platelet function, Thromb. Haemostas., 35: 124, 1976.Google Scholar
  17. 17.
    Sakariassen KS, Fressinaud E, Girma JP, Meyer D, Baumgartner HR: Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen, Ann. New York Acad. Sci., 516: 52, 1987.CrossRefGoogle Scholar
  18. 18.
    Meyer D, Fressinaud E, Sakariassen KS, Baumgartner HR, Girma JP: Role of von Willebrand factor in platelet adhesion, Ann. New York Acad. Sci., 509: 118, 1987.CrossRefGoogle Scholar
  19. 19.
    Fressinaud E, Baruch D, Girma JP, Sakariassen KS, Baumgartner HR, Meyer D: Von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb/IIIa as well as glycoprotein Ib, J. Lab. Clin. Med., 112: 58, 1988.PubMedGoogle Scholar
  20. 20.
    Tschopp TB, Weiss HJ, Baumgartner HR: Interaction of thrombostatic platelets with subendothelium: normal adhesion, absent aggregation, Experientia, 31: 113, 1975.CrossRefPubMedGoogle Scholar
  21. 21.
    Sakariassen KS, Nievelstein PFEM, Coller B, Sixma JJ, The role of platelet membrane glycoprotein Ib and IIb/IIIa in platelet adherence to human artery subendothelium, Br. J. Haematol., 63: 681, 1986.CrossRefPubMedGoogle Scholar
  22. 22.
    Weiss HJ, Turitto VT, Baumgartner HR: Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoprotein IIb-IIIa and storage granules, Blood, 67: 322, 1986.PubMedGoogle Scholar
  23. 23.
    Turitto VT, Weiss HJ, Baumgartner HR: Platelet interaction with rabbit sub-endothelium in von Willebrand’s disease: altered thrombus formation distinct from defective platelet adhesion, J. Clin. Invest., 70: 1730, 1984.CrossRefGoogle Scholar
  24. 24.
    Baumgartner HR, Sakariassen KS: Factors controlling thrombus formation on arterial lesions, Ann. New York Acad. Sci., 454: 162, 1985.CrossRefGoogle Scholar
  25. 25.
    Weiss HJ, Baumgartner HR, Turitto VT: Regulation of platelet-fibrin thrombi on subendothelium, Ann. New York Acad. Sci., 516: 380, 1987.CrossRefGoogle Scholar
  26. 26.
    Hanson SR, Harker LA: Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone, Proc. Natl. Acad. Sci. USA, 85: 3184, 1988.CrossRefPubMedGoogle Scholar
  27. 27.
    Cadroy Y, Harker LA, Hanson SE. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin, J. Lab. Clin. Med., 114: 349, 1989.PubMedGoogle Scholar
  28. 28.
    Turitto VT, Weiss HJ, Baumgartner HR: Rheological factors influencing platelet interaction with vessel surfaces, J. Rheol., 23: 735, 1979.CrossRefGoogle Scholar
  29. 29.
    Turitto VT, Baumgartner HR: Platelet-surface interactions, In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice (Eds., Colman RW, Hirsh J, Marder VJ, Salzman EW), J.B. Lippincott Company, Philadelphia, 1987.Google Scholar
  30. 30.
    Turitto VT: Mass transfer in annuli under conditions of laminar flow, Chem. Engn. Sci., 30; 503, 1975.CrossRefGoogle Scholar
  31. 31.
    Aarts PAMM, van den Broek JATM, Kuiken GDC, Sixma JJ, Heethaar RM: Velocity profiles in annular perfusion chamber measured by laser-doppler velocimetry, J. Biomech., 17: 61, 1984.CrossRefPubMedGoogle Scholar
  32. 32.
    Baumgartner HR: Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood, Haemostasis, 8: 340, 1979.PubMedGoogle Scholar
  33. 33.
    Baumgartner HR, Muggli R, Tschopp TB: Antiplatelet drugs and the interactions between platelets, fibrin and components of the vessel wall, In: Advances in Pharmacology and Therapeutics II (Eds., Yoshida H, Hagihara Y, Ebashi S ), Pergamon Press, Oxford, 1982.Google Scholar
  34. 34.
    Sakariassen KS, Ottenhof-Rovers M, Sixma JJ: Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence, Blood, 63: 996, 1984.PubMedGoogle Scholar
  35. 35.
    Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffmann T: Evidence for the presence of tissue-factor activity on subendothelium, Blood, 73: 968, 1989.PubMedGoogle Scholar
  36. 36.
    Baumgartner HR: Eine neue Methode zur Erzeugung von Thromben durch gezielte Überdehnung der Gefässwand, Z. Gesamte Exp. Med., 137: 227, 1963.CrossRefGoogle Scholar
  37. 37.
    Weiss Fil, Turitto VT, Baumgartner HR: Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects, J. Clin. Invest., 78: 1072, 1986.Google Scholar
  38. 38.
    Roux SP, Sakariassen KS, Turitto VT, Baumgartner HR: Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs: a parallelism between in vivo and ex vivo thrombosis models, Arteriosclerosis and Thrombosis, 11: 1182, 1991.CrossRefPubMedGoogle Scholar
  39. 39.
    Clozel M, Kuhn H, Baumgartner HR, Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood, Blood, 73: 729, 1989.PubMedGoogle Scholar
  40. 40.
    Sakariassen KS, Aznar Salatti J, Anton P, Nemerson Y, Prydz H: Tissue factor/ factor VIIa is the main initiator of coagulation of stimulated endothelium and extracellular matrix of stimulated endothelium, Medicom. Europe BV, Busum, in press.Google Scholar
  41. 41.
    Sakariassen KS, Cousot D, Hadvary P, Baumgartner HR: Aspirin reduces thrombus volume in human non-anticoagulated blood only at shear rates characteristic for stenosed arteries, Thromb. Haemostas., 65: 813, 1991.Google Scholar
  42. 42.
    Baumgartner HR, Turitto VT, Weiss HJ: Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fibrin formation, J. Lab. Clin. Med., 95: 208, 1980.PubMedGoogle Scholar
  43. 43.
    Sakariassen KS, Kuhn H, Muggli R, Baumgartner HR: Growth and stability of thrombi in flowing citrated blood: assessment of platelet-surface interactions with computer-assisted morphometry, Thromb. Haemostas., 60: 392, 1988.Google Scholar
  44. 44.
    Baumgartner HR, Kuhn H, Tschopp TB: Factors influencing the growth, stability and fate of arterial thrombi, In: Atherosclerosis IV (Eds., Schettler G, Gotto AM, Middelhoff G, Habenicht AJR, Jurutka KR ), Springer Verlag, Berlin, 1983.Google Scholar
  45. 45.
    Inauen W, Baumgartner HR, Haeberli A, Straub PW: Excessive deposition of fibrin, platelets and platelet thrombi on vascular subendothelium during contraceptive drug treatment, Thromb. Haemostas., 57: 306, 1987.Google Scholar
  46. 46.
    Sakariassen KS, Baumgartner HR: Axial dependence of platelet-collagen interactions in flowing blood: upstream thrombus growth impairs downstream platelet adhesion, Arteriosclerosis, 9: 33, 1989.CrossRefPubMedGoogle Scholar
  47. 47.
    Sakariassen KS, Weiss HJ, Baumgartner HR: Upstream thrombus growth impairs downstream thrombogenesis in non-anticoagulated blood: effect of procoagulant artery subendothelium and non-procoagulant collagen, Thromb. Haemostas., 65: 596, 1991.Google Scholar
  48. 48.
    Cadroy Y, Hanson SR: Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model, Blood, 75: 2185, 1990.PubMedGoogle Scholar
  49. 49.
    Weiss HJ, Turitto VT, Baumgartner HR: Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear-dependent decrease of adhesion in von Willebrand’s disease and the Bernard-Soulier syndrome, J. Lab. Clin. Med., 92: 750, 1978.Google Scholar
  50. 50.
    Fressinaud E, Sakariassen KS, Rotschild C, Baumgartner HR, Meyer D: Strong impairment of thrombus formation in native blood from patients with von Willebrand disease, Blood, 74: 32 (A), 1989.Google Scholar
  51. 51.
    Weiss HJ, Turitto VT, Baumgartner HR: Further evidence that glycoprotein IIbIIIa mediates platelet spreading on subendothelium, Thromb. Haemostas., 65: 202, 1991Google Scholar
  52. 52.
    Hanson SR, Pareti FI, Ruggeri ZM, Marzec UM, Kunicki TJ, Montgomery RR, Zimmerman TS, Harker LA: Effect of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon, J. Clin. Invest., 81: 149, 1988.CrossRefPubMedGoogle Scholar
  53. 53.
    Cadroy Y, Houghten RA, Hanson SR: RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model, J. Clin. Invest., 84: 939, 1989.CrossRefPubMedGoogle Scholar
  54. 54.
    Weiss HJ, Turitto VT, Vicic WJ, Baumgartner HR: Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood, Thromb. Haemostas., 45: 136, 1981.Google Scholar
  55. 55.
    Plow EJ, Scrouji AH, Meyer D, Marguerie G, Ginsburg MH: Evidence that three adhesive proteins interact with a common recognition site on activated platelets, J. Biol. Chem., 259: 5388, 1984.PubMedGoogle Scholar
  56. 56.
    Weiss HJ, Turitto VT, Vicic WJ, Baumgartner HR: Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency, Blood, 63: 1004, 1984.PubMedGoogle Scholar
  57. 57.
    Weiss HJ, Baumgartner HR, Turitto VT: Regulation of platelet-fibrin thrombi on subendothelium, Ann. New York Acad. Sci., 516: 380, 1987.CrossRefGoogle Scholar
  58. 58.
    Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation, J. Clin. Invest., 78: 1456, 1986.CrossRefPubMedGoogle Scholar
  59. 59.
    Burch JW, Stanford N, Majerus PM- Inhibition of platelet prostaglandin synthetase by oral aspirin, J. Clin. Invest., 6: 314, 1978.CrossRefGoogle Scholar
  60. 60.
    Roth GJ, Majerus PW: The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein, J. Clin. Invest., 56: 624, 1975.CrossRefGoogle Scholar
  61. 61.
    Mombelli G, Monotti R, Haeberli A, Straub PW: Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases, Thromb. Haemostas., 58: 758, 1987.Google Scholar
  62. 62.
    Aznar Salatti J, Anton P, Nemerson Y, Prydz H, Sakariassen KS: The synthetic peptide arg-gly-asp-val inhibits binding of fibrin to the extracellular matrix in flowing non-anticoagulated blood, Thromb. Haemostas., 65: 222, 1991.Google Scholar
  63. 63.
    Cadroy Y, Maraganore JM, Hanson SR, Harker LA: Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons, Proc. Natl. Acad. Sci. USA, 88: 1177, 1991.CrossRefPubMedGoogle Scholar
  64. 64.
    Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson SR, Harker LA: Hirudin interruption of heparin-resistant arterial thrombus formation in baboons, Blood, 77: 1006, 1991.PubMedGoogle Scholar
  65. 65.
    Carson SD, Ross SE, Bach R, Guha A: An inhibitory monoclonal antibody against human tissue factor, Blood, 70: 490, 1987.PubMedGoogle Scholar
  66. 66.
    Sandset PM, Abildgaard U, Larsen ML: Heparin induces release of extrinsic pathway inhibitor (EPI), Thromb. Res., 50: 803, 1988.Google Scholar
  67. 67.
    Lindahl AK, Abildgaard U, Staalesen R: The anticoagulant effect in heparinized blood and plasma resulting from interaction with extrinsic pathway inhibitor, Thromb. Res., in press.Google Scholar
  68. 68.
    Broze G Jr., Miletich JP: Characterization of the inhibition of tissue factor in serum, Blood, 69: 150, 1987.PubMedGoogle Scholar
  69. 69.
    Rao LVM, Rapaport SI: Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation, Blood, 69: 645, 1987.PubMedGoogle Scholar
  70. 70.
    Broze G Jr., Warren LA, Novotny WF, Higuchi DA, Gerard JJ, Miletich JP: The lipoprotein associated coagulation inhibitor inhibits the FVII-tissue factor complex also inhibits FXa: insights into its possible mechanism of action, Blood, 71: 335, 1988.PubMedGoogle Scholar
  71. 71.
    Sobel M, McNeill PM, Carlson PL, Kermode JC, Adelman B, Conroy R, Margues D: Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo, J. Clin. Invest., 87: 1787, 1991.CrossRefPubMedGoogle Scholar
  72. 72.
    Gruber A, Griffin JH, Harker LA, Hanson SR- Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model, Blood, 73: 639, 1989.PubMedGoogle Scholar
  73. 73.
    Gruber A, Hanson SR, Kelly AB, Yan BS, Bang N, Griffin JH, Harker LA: Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis, Circulation, 82: 578, 1990.CrossRefPubMedGoogle Scholar
  74. 74.
    Miller EF, Rhodes RK: Preparation and characterization of the different types of collagen, In: Methods in Enzymology, Academic Press Inc., New York, Vol. 82, 32, 1983.Google Scholar
  75. 75.
    Bruns RR, Gross J: High resolution analysis of the quarter stagger model of the collagen fibril, Biopolymers, 13: 931, 1977.CrossRefGoogle Scholar
  76. 76.
    McCullagh KA, Balion G: Collagen characterization and cell transformation in human atherosclerosis, Nature, 258: 73, 1975.CrossRefPubMedGoogle Scholar
  77. 77.
    Shekonin BV, Domogatsky SP, Idelson GA, Kopteliansky VE, Rukosuev VS: Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries, Atherosclerosis, 67: 9, 1987.CrossRefGoogle Scholar
  78. 78.
    Barnes MJ: Collagens in atherosclerosis, Coll. Rel. Res., 5: 65, 1985.CrossRefGoogle Scholar
  79. 79.
    Nemerson Y: Tissue factor and hemostasis, Blood, 71: 1, 1988.PubMedGoogle Scholar
  80. 80.
    Miletich JP, Jackson CM, Majerus PW: Properties of the factor Xa binding site on human platelets, J. Biol. Chem., 253: 6908, 1978.PubMedGoogle Scholar
  81. 81.
    Rosing J, Bevers EM, Confurius P, Hemker HC, van Dieijen G, Weiss HJ, Zwaal RFA: Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder, Blood, 65: 1557, 1985.PubMedGoogle Scholar
  82. 82.
    Tracy P: Regulation of thrombin generation at cell surfaces, Sem. Thromb. Haemostas., 14: 227, 1988.CrossRefGoogle Scholar
  83. 83.
    Turitto VT: Blood viscosity, mass transfer and thrombogenesis, In: Progress in Hemostasis and Thrombosis (Ed., Spaet TH ), Grune and Stratton, New York, 1982.Google Scholar
  84. 84.
    Aarts PAMM, van den Broek SAT, Prins GW, Kuiken GDC, Sixma JJ, Heethaar RM: Blood platelets are concentrated near the wall and red blood cells in the center of flowing blood, Arteriosclerosis, 8: 819, 1988.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Kjell S. Sakariassen
    • 1
  • Helge E. Roald
    • 1
  • José Aznar Salatti
    • 1
  1. 1.Biotechnology Centre of OsloUniversity of OsloOsloNorway

Personalised recommendations